File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: No evidence for a superior platform to develop therapeutic antibodies rapidly in response to MERS-CoV and other emerging viruses

TitleNo evidence for a superior platform to develop therapeutic antibodies rapidly in response to MERS-CoV and other emerging viruses
Authors
Issue Date2015
Citation
Proceedings of the National Academy of Sciences, 2015, v. 112, p. E5115-E5115 How to Cite?
Persistent Identifierhttp://hdl.handle.net/10722/220053
PubMed Central ID

 

DC FieldValueLanguage
dc.contributor.authorDimiters S, D-
dc.contributor.authorJiang, SB-
dc.contributor.authorYing, TL-
dc.contributor.authorTseng, KCT-
dc.contributor.authorZhang, LQ-
dc.contributor.authorYuen, KY-
dc.date.accessioned2015-10-16T06:27:57Z-
dc.date.available2015-10-16T06:27:57Z-
dc.date.issued2015-
dc.identifier.citationProceedings of the National Academy of Sciences, 2015, v. 112, p. E5115-E5115-
dc.identifier.urihttp://hdl.handle.net/10722/220053-
dc.languageeng-
dc.relation.ispartofProceedings of the National Academy of Sciences-
dc.titleNo evidence for a superior platform to develop therapeutic antibodies rapidly in response to MERS-CoV and other emerging viruses-
dc.typeArticle-
dc.identifier.emailYuen, KY: kyyuen@hkucc.hku.hk-
dc.identifier.authorityYuen, KY=rp00366-
dc.identifier.doi10.1073/pnas.1513441112-
dc.identifier.pmcidPMC4577136-
dc.identifier.hkuros255276-
dc.identifier.volume112-
dc.identifier.spageE5115-
dc.identifier.epageE5115-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats